New evidence-based treatment approach in behçet's disease

Pathology Research International

Volumn 2012, Issue , 2012, Pages

  Alpsoy, Erkan ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862869300     PISSN: None     EISSN: 2042003X     Source Type: Journal    
DOI: 10.1155/2012/871019     Document Type: Review

References (83)

1. Alpsoy E., Behçet's disease: treatment of mucocutaneous lesions. Clinical and Experimental Rheumatology 2005 23 4 532 539 2-s2.0-26844520397 (Pubitemid 41447628)
2. Azizlerli G., Köse A. A., Sarica R., Gül A., Tutkun I. T., Kulaç M., Tunç R., Urganciolu M., Dişçi R., Prevalence of Behçet's disease in Istanbul, Turkey. International Journal of Dermatology 2003 42 10 803 806 2-s2.0-0142186790 10.1046/j.1365-4362.2003. 01893.x (Pubitemid 37304045)
3. Gürler A., Boyvat A., Türsen U., Clinical manifestations of Behçet's disease: an analysis of 2147 patients. Yonsei Medical Journal 1997 38 6 423 427 2-s2.0-0031303180 (Pubitemid 128516403)
4. Zouboulis C. C., Kötter I., Djawari D., Kirch W., Kohl P. K., Ochsendorf F. R., Keitel W., Stadler R., Wollina U., Proksch E., Söhnchen R., Weber H., Gollnick H. P. M., Hölzle E., Fritz K., Licht T., Orfanos C. E., Epidemiological features of adamantiades-Behçet's disease in Germany and in Europe. Yonsei Medical Journal 1997 38 6 411 422 2-s2.0-0031298714 (Pubitemid 128516402)
5. Alpsoy E., Zouboulis C., Ehrlich G. E., Mucocutaneous lesions of Behçet's disease. Yonsei Medical Journal 2007 48 4 573 585 2-s2.0-34848835726 10.3349/ymj.2007.48.4.573 (Pubitemid 47499971)
6. Chamberlain M. A., Behçet's syndrome in 32 patients in Yorkshire. Annals of the Rheumatic Diseases 1977 36 6 491 499 2-s2.0-0017636420
7. Akman A., Sallakci N., Kacaroglu H., Tosun O., Yavuzer U., Alpsoy E., Yegin O., Relationship between periodontal findings and the TNF- α Gene 1031T/C polymorphism in Turkish patients with Behçet's disease. Journal of the European Academy of Dermatology and Venereology 2008 22 8 950 957 2-s2.0-52249085650 10.1111/j.1468-3083.2008.02678.x
8. Ekinci N. S., Alpsoy E., Karakas A. A., Yilmaz S. B., Yegin O., IL-17A has an important role in the acute attacks of Behçet's disease. Journal of Investigative Dermatology 2010 130 8 2136 2138 2-s2.0-77954759960 10.1038/jid.2010.114
9. Akman A., Alpsoy E., Behçet's disease: current aspects in the etiopathogenesis. Turkderm-Archives of the Turkish Dermatology and Venerology 2009 43 supplement 2 32 38
10. Alpsoy E., Aktekin M., Er H., Durusoy C., Yilmaz E., A randomized, controlled and blinded study of papulopustular lesions in Turkish Behçet's patients. International Journal of Dermatology 1998 37 11 839 843 2-s2.0-0031760833 10.1046/j.1365-4362.1998.00401.x (Pubitemid 28545277)
11. Alpsoy E., Donmez L., Bacanli A., Apaydin C., Butun B., Review of the chronology of clinical manifestations in 60 patients with Behçet's disease. Dermatology 2003 207 4 354 356 2-s2.0-0344737920 10.1159/000074113 (Pubitemid 37505781)
12. Tugal-Tutkun I., Onal S., Altan-Yaycioglu R., Huseyin Altunbas H., Urgancioglu M., Uveitis in Behçet disease: an analysis of 880 patients. American Journal of Ophthalmology 2004 138 3 373 380 2-s2.0-4444249490 10.1016/j.ajo.2004.03.022 (Pubitemid 39208563)
13. Yurdakul S., Hamuryudan V., Yazici H., Behçet syndrome. Current Opinion in Rheumatology 2004 16 1 38 42 2-s2.0-0346155812 10.1097/00002281- 200401000-00008 (Pubitemid 38041397)
14. Kural-Seyahi E., Fresko I., Seyahi N., Ozyazgan Y., Mat C., Hamuryudan V., Yurdakul S., Yazici H., The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine 2003 82 1 60 76 2-s2.0-0037246320 10.1097/00005792-200301000-00006 (Pubitemid 36139801)
15. Siva A., Altintas A., Saip S., Behçet's syndrome and the nervous system. Current Opinion in Neurology 2004 17 3 347 357 2-s2.0-2642581617 10.1097/00019052-200406000-00017 (Pubitemid 38720989)
16. Sakane T., Takeno M., Suzuki N., Inaba G., Behçet's disease. The New England Journal of Medicine 1999 341 17 1284 1291 2-s2.0-0033592467 10.1056/NEJM199910213411707 (Pubitemid 29489745)
17. Alpsoy E., Donmez L., Onder M., Gunasti S., Usta A., Karincaoglu Y., Kandi B., Buyukkara S., Keseroglu O., Uzun S., Tursen U., Seyhan M., Akman A., Clinical features and natural course of Behçet's disease in 661 cases: a multicentre study. The British Journal of Dermatology 2007 157 5 901 906 2-s2.0-35348831914 10.1111/j.1365-2133.2007.08116.x (Pubitemid 47583484)
18. Alpsoy E., Akman A., Behçet's disease: an algorithmic approach to its treatment. Archives of Dermatological Research 2009 301 10 693 702 2-s2.0-70349621090 10.1007/s00403-009-0990-2
19. Alpsoy E., Akman A., Treatment of Behçet's disease. Therapy 2006 3 1 139 151 2-s2.0-33646175704 10.1586/14750708.3.1.139
20. Meiller T. F., Kutcher M. J., Overholser C. D., Niehaus C., DePaola L. G., Siegel M. A., Effect of an antimicrobial mouthrinse on recurrent aphthous ulcerations. Oral Surgery Oral Medicine and Oral Pathology 1991 72 4 425 429 2-s2.0-0026001574
21. Addy M., Carpenter R., Roberts W. R., Management of recurrent aphthous ulceration. A trial of chlorhexidine gluconate gel. The British Dental Journal 1976 141 4 118 120 2-s2.0-0017309908 10.1038/sj.bdj.4803798
22. Skaare A. B., Herlofson B. B., Barkvoll P., Mouthrinses containing triclosan reduce the incidence of recurrent aphthous ulcers (RAU). Journal of Clinical Periodontology 1996 23 778 781 (Pubitemid 126732030)
23. Graykowski E. A., Kingman A., Double-blind trial of tetracycline in recurrent aphthous ulceration. Journal of Oral Pathology 1978 7 6 376 382 2-s2.0-0018234440 (Pubitemid 9104329)
24. Gorsky M., Epstein J. B., Rabenstein S., Elishoov H., Yarom N., Topical minocycline and tetracycline rinses in treatment of recurrent aphthous stomatitis: a randomized cross-over study. Dermatology Online Journal 2007 13 2, article 1 2-s2.0-34248160502
25. Bang D., Treatment of Behçet's disease. Yonsei Medical Journal 1997 38 6 401 410 2-s2.0-0031283186
26. Kerr A. R., Drexel C. A., Spielman AI., The efficacy and safety of 50 mg penicillin G potassium troches for recurrent aphthous ulcers. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology & Endodontics 2003 96 685 694 (Pubitemid 37550075)
27. Alpsoy E., Er H., Durusoy C., Yilmaz E., The use of sucralfate suspension in the treatment of oral and genital ulceration of Behçet's disease: a randomized, placebo-controlled, double-blind study. Archives of Dermatology 1999 135 5 529 532 2-s2.0-0032898968 10.1001/archderm.135.5.529 (Pubitemid 29222295)
28. Chams-Davatchi C., Barikbin B., Shahram F., Nadji A., Moghaddassi M., Yousefi M., Davatchi F., Pimecrolimus versus placebo in genital aphthous ulcers of Behçet's disease: a randomized double-blind controlled trial. International Journal of Rheumatic Diseases 2010 13 3 253 258 2-s2.0-77955403936 10.1111/j.1756-185X.2010.01531.x
29. Köse O., Dinç A., Şimşek I., Randomized trial of pimecrolimus cream plus colchicine tablets versus colchicine tablets in the treatment of genital ulcers in Behçet's disease. Dermatology 2009 218 2 140 145 2-s2.0-59049099968 10.1159/000182257
30. Binnie W. H., Curro F. A., Khandwala A., Van Inwegan R. G., Amlexanox oral paste: a novel treatment that accelerates the healing of aphthous ulcers. Compendium of Continuing Education in Dentistry 1997 18 11 1116 1124 2-s2.0-0031266739
31. Greer R. O. Jr., Lindenmuth J. E., Juarez T., Khandwala A., Kaugars G. E., A double-blind study of topically applied 5 amlexanox in the treatment of aphthous ulcers. Journal of Oral and Maxillofacial Surgery 1993 51 3 243 248 2-s2.0-0027447014
32. Conklin R. J., Blasberg B., Common inflammatory diseases of the mouth. International Journal of Dermatology 1991 30 5 323 335 2-s2.0-0025774862
33. Saxen M. A., Ambrosius W. T., Rehemtula Al-K. F., Russell A. L., Eckert G. J., Sustained relief of oral aphthous ulcer pain from topical diclofenac in hyaluronan: a randomized, double-blind clinical trial. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology & Endodontics 1997 84 356 361 (Pubitemid 127670986)
34. Bacanli A., Yerebakan O., Parmaksizoglu B., Yilmaz E., Alpsoy E., Topical granulocyte colony-stimulating factor for the treatment of oral and genital ulcers of patients with Behçet's disease. Journal of the European Academy of Dermatology and Venereology 2006 20 8 931 935 2-s2.0-33747377729 10.1111/j.1468-3083.2006.01677.x
35. Akman A., Kacaroglu H., Donmez L., Bacanli A., Alpsoy E., Relationship between periodontal findings and Behçet's disease: a controlled study. Journal of Clinical Periodontology 2007 34 6 485 491 2-s2.0-34248531795 10.1111/j.1600-051X.2007.01085.x
36. Mat C., Yurdakul S., Uysal S., Gogus F., Ozyazgan Y., Uysal O., Fresko I., Yazici H., A double-blind trial of depot corticosteroids in Behçet's syndrome. Rheumatology 2006 45 3 348 352 2-s2.0-33644871933 10.1093/ rheumatology/kei165 (Pubitemid 43372853)
37. Aktulga E., Altac M., Muftuoglu A., A double blind study of colchicine in Behçet's disease. Haematologica 1980 65 3 399 402 2-s2.0-0019148838 (Pubitemid 11254772)
38. Yurdakul S., Mat C., Tuzun Y., Ozyazgan Y., Hamuryudan V., Uysal O., Enocak M., Yazici H., A double-blind trial of colchicine in Behçet's syndrome. Arthritis and Rheumatism 2001 44 11 2686 2692 2-s2.0-0035152002 10.1002/1529-0131(200111)44:112686::AID-ART448>3.0.CO;2-H (Pubitemid 33049346)
39. Davatchi F., Sadeghi Abdollahi B., Tehrani Banihashemi A., Shahram F., Nadji A., Shams H., Chams-Davatchi C., Colchicine versus placebo in Behçet's disease: randomized, double-blind, controlled crossover trial. Modern Rheumatology 2009 19 5 542 549 2-s2.0-70350003692 10.1007/s10165-009- 0200-2
40. Çalgüneri M., Ertenli I., Kiraz S., Erman M., Çelik I., Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behçet's disease. Dermatology 1996 192 2 125 128 2-s2.0-0030026038
41. Al-Waiz M. M., Sharquie K. E., A-Qaissi M. H., Hayani R. K., Colchicine and benzathine penicillin in the treatment of Behçet disease: a case comparative study. Dermatology Online Journal 2005 11 3, article 3 2-s2.0-29844455215
42. Matsuda T., Ohno S., Hirohata S., Miyanaga Y., Ujihara H., Inaba G., Nakamura S., Tanaka S. I., Kogure M., Mizushima Y., Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet's disease: a randomised, double-blind, placebo-controlled study. Drugs in R and D 2003 4 1 19 28 2-s2.0-0041355284 10.2165/00126839-200304010-00002 (Pubitemid 37062641)
43. Sharquie K. E., Najim R. A., Al-Dori W. S., Al-Hayani R. K., Oral zinc sulfate in the treatment of Behçet's disease: a double blind cross-over study. Journal of Dermatology 2006 33 8 541 546 2-s2.0-33746586079 10.1111/j.1346-8138.2006.00128.x (Pubitemid 44154792)
44. Sharquie K. E., Najim R. A., Abu-Raghif A. R., Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study. Journal of Dermatology 2002 29 5 267 279 2-s2.0-0036303844 (Pubitemid 34742240)
45. Hamuryudan V., Mat C., Saip S., Özyazgan Y., Siva A., Yurdakul S., Zwingenberger K., Yazici H., Thalidomide in the treatment of the mucocutaneous lesions of the Behçet's syndrome: a randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine 1998 128 6 443 450 2-s2.0-0032520803
46. Yazici H., Pazarli H., Barnes C. G., Tuzun Y., Ozyazgan Y., Silman A., Serdaroglu S., Oguz V., Yurdakul S., Lovatt G. E., Yazici B., Somani S., Muftuoglu A., A controlled trial of azathioprine in Behçet's syndrome. The New England Journal of Medicine 1990 322 5 281 285 2-s2.0-0025014790 (Pubitemid 20046329)
47. Davatchi F., Shahram F., Chams H., Akbarian M., Pulse cyclophosphamide (PCP) for ocular lesions of Behçet's disease: double blind crossover study. Arthritis & Rheumatism 1999 42 S320
48. Masuda K., Nakajima A., Urayama A., Nakae K., Kogure M., Inaba G., Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease. The Lancet 1989 1 8647 1093 1096 2-s2.0-0024565498 (Pubitemid 19128039)
49. BenEzra D., Cohen E., Chajek T., Friedman G., Pizanti S., De Courten C., Harris W., Evaluation of conventional therapy versus cyclosporine A in Behçet's syndrome. Transplantation Proceedings 1988 20 3 136 143 2-s2.0-0023949427
50. Elidan J., Cohen E., Levi H., Benezra D., Effect of cyclosporine A on the hearing loss in Behçet's disease. Annals of Otology, Rhinology and Laryngology 1991 100 6 464 468 2-s2.0-0025728895
51. Ozyazgan Y., Yurdakul S., Yazici H., Tuzun B., Iscimen A., Yalcin T., Aktunc T., Pazarli H., Hamuryudan V., Muftuoglo A., Low dose cyclosporin A versus pulsed cyclophosphamide in Behçet's syndrome: a single masked trial. The British Journal of Ophthalmology 1992 76 4 241 243 2-s2.0-0026568203
52. Assaad-Khalil S. H., O'Duffy J. D., Kokmen E., Low-dose cyclosporin in Behçet's disease: follow-up controlled study with emphasis on extraocular manifestations and neuro-Behçet's disease. Behçet's Disease: Basic and Clinical Aspects 1991 New York, NY, USA Marcel Dekker 603 612
53. Kötter I., Günaydin I., Batra M., Vonthein R., Stübiger N., Fierlbeck G., Melms A., CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medicationsresults of a retrospective analysis of 117 cases. Clinical Rheumatology 2006 25 4 482 486 2-s2.0-33746549075 10.1007/s10067-005-0070-8 (Pubitemid 44137619)
54. Alpsoy E., Durusoy C., Yilmaz E., Ozgurel Y., Ermis O., Yazar S., Basaran E., Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study. Archives of Dermatology 2002 138 4 467 471 2-s2.0-0036217303 (Pubitemid 34290024)
55. Hamuryudan V., Moral F., Yurdakul S., Mat C., Tuzun Y., Ozyazgan Y., Dreskeneli H., Akoglu T., Yazici H., Systemic interferon α 2b treatment in Behçet's syndrome. Journal of Rheumatology 1994 21 6 1098 1100 2-s2.0-0028279533 (Pubitemid 24182284)
56. Kötter I., Zierhut M., Eckstein A. K., Vonthein R., Ness T., Günaydin I., Grimbacher B., Blaschke S., Meyer-Riemann W., Peter H. H., Stübiger N., Human recombinant interferon alpha-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis. The British Journal of Ophthalmology 2003 87 4 423 431 2-s2.0-0345701528 10.1136/bjo.87.4.423 (Pubitemid 36399030)
57. Tugal-Tutkun I., Guney-Tefekli E., Urgancioglu M., Results of interferon-alfa therapy in patients with Behçet uveitis. Graefe's Archive for Clinical and Experimental Ophthalmology 2006 244 1692 1695 (Pubitemid 44830831)
58. Onal S., Kazokoglu H., Koc A., Long-term efficacy and safety of low-dose and dose-escalating interferon alfa-2a therapy in refractory Behçet uveitis. Archives of Ophthalmology 2011 129 3 288 294
59. Sfikakis P. P., Kaklamanis P. H., Elezoglou A., Katsilambros N., Theodossiadis P. G., Papaefthimiou S., Markomichelakis N., Infliximab for recurrent, sight-threatening ocular inflammation in adamantiades-Behçet disease. Annals of Internal Medicine 2004 140 5 404 406 2-s2.0-1442357109 (Pubitemid 38268925)
60. Ohno S., Nakamura S., Hori S., Shimakawa M., Kawashima H., Mochizuki M., Sugita S., Ueno S., Yoshizaki K., Inaba G., Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis. Journal of Rheumatology 2004 31 7 1362 1368 2-s2.0-3042811083 (Pubitemid 38879203)
61. Tugal-Tutkun I., Mudun A., Urgancioglu M., Kamali S., Kasapoglu E., Inanc M., Gül A., Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial. Arthritis and Rheumatism 2005 52 8 2478 2484 2-s2.0-23644447065 10.1002/art.21231 (Pubitemid 41117435)
62. Sfikakis P. P., Markomichelakis N., Alpsoy E., Assaad-Khalil S., Bodaghi B., Gul A., Ohno S., Pipitone N., Schirmer M., Stanford M., Wechsler B., Zouboulis C., Kaklamanis P., Yazici H., Anti-TNF therapy in the management of Behçet's diseasereview and basis for recommendations. Rheumatology 2007 46 5 736 741 2-s2.0-34347212190 10.1093/rheumatology/kem034 (Pubitemid 47061701)
63. Mushtaq B., Saeed T., Situnayake R. D., Murray P. I., Adalimumab for sight-threatening uveitis in Behçet's disease. Eye 2007 21 6 824 825 2-s2.0-34250366261 10.1038/sj.eye.6702352 (Pubitemid 46909189)
64. Melikoglu M., Fresko I., Mat C., Ozyazgan Y., Gogus F., Yurdakul S., Hamuryudan V., Yazici H., Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study. Journal of Rheumatology 2005 32 1 98 105 2-s2.0-11844283956 (Pubitemid 40092599)
65. Davatchi F., Shams H., Rezaipoor M., Sadeghi-Abdollahi B., Shahram F., Nadji A., Chams-Davatchi C., Akhlaghi M., Faezi T., Naderi N., Rituximab in intractable ocular lesions of Behçet's disease; randomized single-blind control study (pilot study). International Journal of Rheumatic Diseases 2010 13 3 246 252 2-s2.0-77955356607 10.1111/j.1756-185X.2010.01546.x
66. Jorizzo J. L., White W. L., Wise C. M., Zanolli M. D., Sherertz E. F., Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: cutaneous polyarteritis nodosa and Behçet's disease. Journal of the American Academy of Dermatology 1991 24 6 973 978 2-s2.0-0025940046
67. Kikuchi H., Aramaki K., Hirohata S., Low dose MTX for progressive neuro-Behçet's disease. A follow-up study for 4 years. Advances in Experimental Medicine and Biology 2003 528 575 578 2-s2.0-0642369390
68. Suda H., Low-dose weekly methotrexate therapy for progressive neuro-Behçet's disease. Nihon Rinsho Meneki Gakkai kaish 1999 22 1 13 22 2-s2.0-0033068627
69. Davatchi F., Shahram F., Chams H., Jamshidi A. R., Nadji A., Chams C., Akbarian M., Gharibdoost F., High dose methotrexate for ocular lesions of Behçet's disease. Preliminary short-term results. Advances in Experimental Medicine and Biology 2003 528 579 584 2-s2.0-0642338779
70. Neri P., Mariotti C., Cimino L., Mercanti L., Giovannini A., Long-term control of cystoid macular oedema in noninfectious uveitis with Mycophenolate Mofetil. International Ophthalmology 2009 29 3 127 133 2-s2.0-67349131139 10.1007/s10792-008-9200-z
71. Adler Y. D., Mansmann U., Zouboulis C. C., Mycophenolate mofetil is ineffective in the treatment of mucocutaneous Adamantiades-Behçet's disease. Dermatology 2001 203 4 322 324 2-s2.0-0035674190 10.1159/000051781 (Pubitemid 34045195)
72. Rossi G., Moretta A., Locatelli F., Autologous hematopoietic stem cell transplantation for severe/refractory intestinal Behçet's disease. Blood 2004 103 2 748 750 2-s2.0-0942266014 10.1182/blood-2003-10-3617 (Pubitemid 38140118)
73. Maurer B., Hensel M., Max R., Fiehn C., Ho A. D., Lorenz H. M., Autologous haematopoietic stem cell transplantation for Behçet's disease with pulmonary involvement: analysis after 5 years of follow up. Annals of the Rheumatic Diseases 2006 65 1 127 129 2-s2.0-29144483294 10.1136/ard.2005.035410 (Pubitemid 41815655)
74. De Cata A., Intiso D., Bernal M., Molinaro F., Mazzoccoli G., D'Alessandro V., Greco A., Curci S., Sperandeo M., Frusciante V., Famularo G., Dallapiccola B., Vendemiale G., Prolonged remission of neuro-Behçet's disease following autologous transplantation. International Journal of Immunopathology and Pharmacology 2007 20 1 91 96 2-s2.0-33947721840 (Pubitemid 46506879)
75. Yasui K., Ohta K., Kobayashi M., Aizawa T., Komiyama A., Successful treatment of Behçet disease with pentoxifylline. Annals of Internal Medicine 1996 124 10 891 893 2-s2.0-0029664831
76. Oliveira-Soares R., Freitas J. P., Sousa Ramalho P., Guerra Rodrigo F., Treatment with pentoxifylline in Behçet's disease. Journal of the European Academy of Dermatology and Venereology 2002 16 2 181 182 2-s2.0-0036238916 10.1046/j.1468-3083.2002.003928.x
77. Can M., Direskeneli H., Musculo-skeletal and vascular involvement in Behçet's disease. Turkderm-Archives of the Turkish Dermatology and Venerology 2009 43 supplement 2 54 60
78. Aroussi A. A., Redai M., El Ouardi F., Mehadji B. E., Bilateral pulmonary artery aneurysm in Behçet syndrome: report of two operative cases. Journal of Thoracic and Cardiovascular Surgery 2005 129 5 1170 1171 2-s2.0-18244386457 10.1016/j.jtcvs.2004.08.038 (Pubitemid 40631442)
79. Koo B. K., Shim W. H., Yoon Y. S., Lee B. K., Choi D., Jang Y., Lee D. Y., Chang B. C., Endovascular therapy combined with immunosuppressive treatment for pseudoaneurysms in patients with Behçet's disease. Journal of Endovascular Therapy 2003 10 1 75 80 2-s2.0-0038689379 10.1583/1545-1550(2003) 0100075:ETCWIT>2.0.CO;2 (Pubitemid 36644829)
80. Soylu M., Demircan N., Pelit A., Pars plana vitrectomy in ocular Behçet's disease. International Ophthalmology 2001 24 4 219 223 2-s2.0-0242500848 10.1023/A:1022587012611 (Pubitemid 36372091)
81. Alexoudi I., Kapsimali V., Vaiopoulos A., Kanakis M., Vaiopoulos G., Evaluation of current therapeutic strategies in Behçet's disease. Clinical Rheumatology 2011 30 2 157 163 2-s2.0-77956462223 10.1007/s10067-010- 1566-4
82. Hatemi G., Silman A., Bang D., EULAR recommendations for the management of Behçet's disease: report of a task force of the European Standing Committee for International Clinical Sstudies Including Therapeutics (ESCISIT). Annals of the Rheumatic Diseases 2008 67 1656 1662
83. Akman-Demir A., Neurologic involvement in Behçet's disease. Turkderm-Archives of the Turkish Dermatology and Venerology 2009 43 supplement 2 61 64